Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Structure

3 Ways to Invest in the Growing GLP-1 Weight Loss Market

GLP-1 drugs are big business, and investors can win rewards by searching beyond the biggest names or diversifying via ETFs.

MarketBeat · Apr 17

Nike Structure Plus review: Premium stability without the stigma

Nike’s premium take on stability shoes blends ZoomX cushioning, subtle support and everyday wearability, without looking like a medical device

T3 · Jan 28

2 ‘Monster’ Stocks to Snap Up Before 2025

Analysts at Jefferies have identified Metagenomi and Structure Therapeutics as two "monster" stocks in the biotech sector, with potential gains of up to 1,000%.

Barchart · Dec 12, 2024

From analysis to the latest developments in health,
read the most diverse news in one place.

Structure Therapeutics vs. Viking Therapeutics: Which Weight-Loss Drug Stock Wins?

With weight-loss drugs gaining traction, which biopharma stock wins?

Barchart · Jun 6, 2024

This Weight-Loss Stock Could Surge 75%, Says JPMorgan

Structure Therapeutics is a clinical-stage weight-loss company that is poised to gain traction in a rapidly expanding addressable market.

Barchart · May 29, 2024

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Viking Therapeutics Inc

10 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.